Viewing Study NCT00555867


Ignite Creation Date: 2025-12-25 @ 12:45 AM
Ignite Modification Date: 2026-03-03 @ 12:41 AM
Study NCT ID: NCT00555867
Status: TERMINATED
Last Update Posted: 2011-12-23
First Post: 2007-11-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Patient's Anastrozole Compliance to Therapy Programme
Sponsor: AstraZeneca
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None hormone-receptor positive primary breast cancer View
None compliance View
None Postmenopausal women View